An Efficacious Endometrial Sampler for Screening Endometrial Cancer

Recently, the research on early detection of precancerous change and endometrial carcinoma has been focusing on minimally invasive procedures for screening. On this basis, we aim to verify the feasibility of endometrial samplers for screening endometrial cancer using Li Brush. We recruited patients...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2019-02, Vol.9, p.67-67
Main Authors: Han, Lu, Du, Jiang, Zhao, Lanbo, Sun, Chao, Wang, Qi, Tuo, Xiaoqian, Hou, Huilian, Liu, Yu, Wang, Qing, Ulain, Qurat, Lv, Shulan, Zhang, Guanjun, Song, Qing, Li, Qiling
Format: Article
Language:English
Subjects:
cytology
endometrial cancer
endometrial sampler
histopathology
Oncology
screening
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recently, the research on early detection of precancerous change and endometrial carcinoma has been focusing on minimally invasive procedures for screening. On this basis, we aim to verify the feasibility of endometrial samplers for screening endometrial cancer using Li Brush. We recruited patients undergoing hysterectomy for different diseases from the Inpatient Department of the Department of Obstetrics and Gynecology. Before surgery, endometrial cells were collected by Li Brush. The cytopathologic diagnosis from Li Brush and the histopathologic diagnosis from hysterectomy in the same patient were compared to calculate sensitivity (Se), specificity (Sp), false-negative rate (FNR), false-positive rate (FPR), positive predictive value (PV+) %, and negative predictive value (PV-). The research enrolled 293 women into this self-controlled trial. According to the hypothesis test of paired four lattices, we obtained the following indicators: Se 92.73, Sp 98.15, FNR 7.27, FPR 1.85, PV+92.73, and PV-98.15%. The endometrial sampler Li Brush is an efficacious instrument for screening endometrial cancer.
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2019.00067